HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Diagnostic accuracy of the FluoroType MTB and MTBDR VER 2.0 assays for the centralized high-throughput detection of Mycobacterium tuberculosis complex DNA and isoniazid and rifampicin resistance.

AbstractOBJECTIVES:
To evaluate the accuracy of two new molecular diagnostic tests for the detection of drug-resistant tuberculosis, the FluoroType MTB and MTBDR VER 2.0 assays, in combination with manual and automated DNA extraction methods.
METHODS:
Sputa from 360 Xpert Ultra Mycobacterium tuberculosis complex (MTBC)-positive patients and 250 Xpert Ultra MTBC-negative patients were tested. GenoType MTBDRplus served as reference for MTBC and drug resistance detection. Sanger sequencing was used to resolve discrepancies.
RESULTS:
FluoroType MTB VER 2.0 showed similar MTBC sensitivity compared with FluoroType MTBDR VER 2.0 (manual DNA extraction: 91.6% (294/321) versus 89.8% (291/324); p 0.4); automated DNA extraction: 92.1% (305/331) versus 87.7% (291/332); p 0.05)). FluoroType MTBDR VER2.0 showed comparable diagnostic accuracy to FluoroType MTBDR VER1.0 as previously reported for the detection of MTBC and rifampicin and isoniazid resistance.
CONCLUSIONS:
The FluoroType MTB and MTBDR VER 2.0 assays together with an automated DNA extraction and PCR set-up platform may improve laboratory operational efficiency for the diagnosis of MTBC and resistance to rifampicin and isoniazid and show promise for the implementation in a centralized molecular drug susceptibility testing model.
AuthorsAnzaan Dippenaar, Brigitta Derendinger, Tania Dolby, Natalie Beylis, Paul D van Helden, Grant Theron, Robin M Warren, Margaretha de Vos
JournalClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (Clin Microbiol Infect) Vol. 27 Issue 9 Pg. 1351.e1-1351.e4 (Sep 2021) ISSN: 1469-0691 [Electronic] England
PMID33933566 (Publication Type: Comparative Study, Evaluation Study, Journal Article)
CopyrightCopyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Chemical References
  • Antitubercular Agents
  • DNA, Bacterial
  • Isoniazid
  • Rifampin
Topics
  • Antitubercular Agents (pharmacology)
  • DNA, Bacterial (isolation & purification)
  • Drug Resistance, Bacterial
  • Humans
  • Isoniazid (pharmacology)
  • Microbial Sensitivity Tests
  • Molecular Diagnostic Techniques
  • Mycobacterium tuberculosis (drug effects, genetics)
  • Rifampin (pharmacology)
  • Sensitivity and Specificity
  • Tuberculosis (diagnosis, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: